Skip to main content
Fig. 6 | Journal of Nanobiotechnology

Fig. 6

From: Combining hydrophilic chemotherapy and hydrophobic phytotherapy via tumor-targeted albumin–QDs nano-hybrids: covalent coupling and phospholipid complexation approaches

Fig. 6

IC50 of free RSV, free PMT and free RSV/PMT co-solvent compared to the prepared nano-formulations F2 (RSV/PMT-BSA-QDs NPs), F3 (Mann-targeted RSV/PMT BSA-QDs NPs), and F4 (Mann-targeted RSV-PMT BSA NPs) on MCF-7 (a) and MDA-MB-231 (b) breast cancer cell line at the concentration of 0–60 μg/ml after 24 h. *p < 0.05 vs. Free drug, #p < 0.05 vs. Free RSV/PMT solution, $p < 0.05 vs. the drug in F1, øp < 0.05 vs. the drug in F2, πp < 0.05 vs. the drug in F3

Back to article page

Journal of Nanobiotechnology

ISSN: 1477-3155

Contact us